Targeted Medical Pharma Gross Margin 2014-2015 | TRGM
Current and historical gross margin for Targeted Medical Pharma (TRGM) over the last 10 years. The current gross profit margin for Targeted Medical Pharma as of December 31, 2015 is %.
| Targeted Medical Pharma Gross Margin Historical Data |
| Date |
TTM Revenue |
TTM Gross Profit |
Gross Margin |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Generic Drugs |
$0.000B |
$0.000B |
|
Targeted Medical Pharma, Inc. is a biotechnology company. It develops amino acid based medical foods for the treatment of chronic disease, including pain syndromes, peripheral neuropathy, hypertension, obesity, sleep and cognitive disorders. The Company also develops a line of dietary supplements designed to support health and wellness. It is also developing nutrient-based systems for oral stimulation of progenitor stem cells that differentiate into neurons, red blood cells, pituitary hormones including IGF-I. Targeted Medical Pharma, Inc. is based in Los Angeles, California.
|
